AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 7980302 — intervention group
Group type: EXPERIMENTAL
Intervention: Prostaglandin E2 (PGE2) vaginal pessaries
Number of subjects: 206
Study 7980302 — intervention group
Group type: COMPARATOR
Intervention: Amniotomy plus oxytocin infusion
Number of subjects: 206
Study 2691943 — intervention group
Group type: EXPERIMENTAL
Intervention: Factor AF2
Number of subjects: 0
Study 2691943 — intervention group
Group type: COMPARATOR
Intervention: Control group (no Factor AF2)
Number of subjects: 0
Study 4850376 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.25 mg digoxin tablet (Lanoxin)
Number of subjects: 6
Study 4850376 — intervention group
Group type: EXPERIMENTAL
Intervention: digoxin solution
Number of subjects: 6
Study 4850376 — intervention group
Group type: EXPERIMENTAL
Intervention: oral administration of digoxin (0.25 mg)
Number of subjects: 6
Study 4850376 — intervention group
Group type: EXPERIMENTAL
Intervention: intravenous administration of digoxin (0.25 mg)
Number of subjects: 6
Study 4850376 — intervention group
Group type: EXPERIMENTAL
Intervention: urinary excretion of digoxin
Number of subjects: 6
Study 31498937 — intervention group
Group type: EXPERIMENTAL
Intervention: Osteo-cise: Strong Bones for Life multicomponent exercise program (n = 81)
Number of subjects: 162
Study 31498937 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 81)
Number of subjects: 162
Study 31498937 — intervention group
Group type: EXPERIMENTAL
Intervention: Osteo-cise (per protocol analysis with ≥66% exercise adherence)
Number of subjects: 162
Study 31446994 — intervention group
Group type: EXPERIMENTAL
Intervention: Pembrolizumab (200 mg Q3W) as first-line therapy
Number of subjects: 264
Study 31446994 — intervention group
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Number of subjects: 264
Study 29940953 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-managed continuous monitoring
Number of subjects: 225
Study 29940953 — intervention group
Group type: COMPARATOR
Intervention: Supervision (control)
Number of subjects: 225
Study 26580275 — intervention group
Group type: EXPERIMENTAL
Intervention: HFR-iso
Number of subjects: 47
Study 26580275 — intervention group
Group type: COMPARATOR
Intervention: HFR
Number of subjects: 47
Study 23733488 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg saffron tablets for 7 days
Number of subjects: 60
Study 23733488 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 mg saffron tablets for 7 days
Number of subjects: 60
Study 23733488 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 7 days
Number of subjects: 60
Study 22258269 — intervention group
Group type: EXPERIMENTAL
Intervention: Lipid-based nutrient supplement (LNS)
Number of subjects: 2369
Study 22258269 — intervention group
Group type: EXPERIMENTAL
Intervention: Antiretroviral drugs
Number of subjects: 2369
Study 22258269 — intervention group
Group type: EXPERIMENTAL
Intervention: Lipid-based nutrient supplement (LNS) with antiretroviral drugs
Number of subjects: 2369
Study 22258269 — intervention group
Group type: EXPERIMENTAL
Intervention: Lipid-based nutrient supplement (LNS) without antiretroviral drugs
Number of subjects: 2369
Study 19130041 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle intervention (diet rich in natural fibre and moderate to vigorous leisure time physical activity)
Number of subjects: 406
Study 19130041 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased fibre intake and moderate to vigorous leisure time physical activity
Number of subjects: 406
Study 19130041 — intervention group
Group type: EXPERIMENTAL
Intervention: Changes in carbohydrate or fat intake
Number of subjects: 406
Study 17998028 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 meal per day
Number of subjects: 0
Study 17998028 — intervention group
Group type: COMPARATOR
Intervention: 3 meals per day
Number of subjects: 0
Study 15249438 — intervention group
Group type: EXPERIMENTAL
Intervention: APAPfl (AutoSet device)
Number of subjects: 30
Study 15249438 — intervention group
Group type: COMPARATOR
Intervention: APAPfot (SOMNOsmart device)
Number of subjects: 30
Study 11999177 — intervention group
Group type: EXPERIMENTAL
Intervention: Instruction group
Number of subjects: 10
Study 11999177 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 10
Study 10202984 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcranial magnetic stimulation applied daily for 10 days
Number of subjects: 10
Study 9282669 — intervention group
Group type: EXPERIMENTAL
Intervention: Time-of-flight MR angiography
Number of subjects: 20
Study 9282669 — intervention group
Group type: COMPARATOR
Intervention: Intra-arterial contrast angiography
Number of subjects: 20
Study 2314405 — intervention group
Group type: EXPERIMENTAL
Intervention: Bovine surfactant (20-40 mg/kg in group 1, 40-50 mg/kg in group 2)
Number of subjects: 32
Study 85109 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural injection of 2 mg morphine
Number of subjects: 10
Study 31606361 — intervention group
Group type: EXPERIMENTAL
Intervention: Random Forest (RF) model
Number of subjects: 0
Study 30944885 — intervention group
Group type: EXPERIMENTAL
Intervention: Highlights version of the informed consent document (Common Rule)
Number of subjects: 0
Study 30944885 — intervention group
Group type: COMPARATOR
Intervention: Full-length version of the informed consent document
Number of subjects: 0
Study 30944885 — intervention group
Group type: EXPERIMENTAL
Intervention: Other revised versions of the informed consent document
Number of subjects: 0
Study 27264211 — intervention group
Group type: EXPERIMENTAL
Intervention: Isometric exercise (30% maximal voluntary contraction for 3 minutes)
Number of subjects: 20
Study 27264211 — intervention group
Group type: COMPARATOR
Intervention: Control condition (quiet rest)
Number of subjects: 20
Study 26419418 — intervention group
Group type: EXPERIMENTAL
Intervention: 1:1 cognitive tutoring for eight weeks
Number of subjects: 0
Study 25251736 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic SpineCor brace
Number of subjects: 68
Study 25251736 — intervention group
Group type: COMPARATOR
Intervention: Natural evolution (control)
Number of subjects: 68
Study 20870753 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebulized gentamicin, 80 mg, twice daily for 12 months
Number of subjects: 65
Study 20870753 — intervention group
Group type: COMPARATOR
Intervention: Nebulized saline, 0.9% for 12 months
Number of subjects: 65
Study 19378225 — intervention group
Group type: EXPERIMENTAL
Intervention: Triaxial accelerometer (RT3, Stayhealthy, Monrovia, CA) worn during waking hours over a 14-day period
Number of subjects: 22
Study 19378225 — intervention group
Group type: EXPERIMENTAL
Intervention: Triaxial accelerometer (RT3, Stayhealthy, Monrovia, CA) worn during mid-day hours (10AM to 4PM)
Number of subjects: 22
Study 17540969 — intervention group
Group type: EXPERIMENTAL
Intervention: Women
Number of subjects: 569
Study 17540969 — intervention group
Group type: COMPARATOR
Intervention: Men
Number of subjects: 569
Study 15223674 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium valproate (400 mg four times per day)
Number of subjects: 22
Study 11268865 — intervention group
Group type: EXPERIMENTAL
Intervention: Chorioamnion cultures positive for coagulase-negative staphylococci (CONS)
Number of subjects: 108
Study 11268865 — intervention group
Group type: COMPARATOR
Intervention: Chorioamnion cultures negative for coagulase-negative staphylococci (CONS)
Number of subjects: 108
Study 11268865 — intervention group
Group type: EXPERIMENTAL
Intervention: Culture-proven CONS in the NICU
Number of subjects: 108
Study 11268865 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjusted odds ratio for CONS in chorioamnion
Number of subjects: 108
Study 11268865 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjusted odds ratio for CONS in NICU
Number of subjects: 108
Study 9642893 — intervention group
Group type: EXPERIMENTAL
Intervention: Community Reinforcement Approach (CRA)
Number of subjects: 106
Study 9642893 — intervention group
Group type: COMPARATOR
Intervention: Standard Treatment (STD)
Number of subjects: 106
Study 9820995 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril treatment
Number of subjects: 534
Study 9820995 — intervention group
Group type: EXPERIMENTAL
Intervention: Atrial natriuretic peptide
Number of subjects: 534
Study 9820995 — intervention group
Group type: EXPERIMENTAL
Intervention: Aldosterone
Number of subjects: 534
Study 9820995 — intervention group
Group type: EXPERIMENTAL
Intervention: Norepinephrine
Number of subjects: 534
Study 9820995 — intervention group
Group type: EXPERIMENTAL
Intervention: Epinephrine
Number of subjects: 534
Study 9820995 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-month plasma atrial natriuretic peptide and aldosterone
Number of subjects: 534
Study 9820995 — intervention group
Group type: EXPERIMENTAL
Intervention: Neurohormones (atrial natriuretic peptide, aldosterone, norepinephrine)
Number of subjects: 534
Study 2071264 — intervention group
Group type: COMPARATOR
Intervention: 800 mg of garlic powder for four weeks
Number of subjects: 0
Study 6868954 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 g of myoinositol daily for 2 months
Number of subjects: 28
Study 6868954 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study 31672712 — intervention group
Group type: EXPERIMENTAL
Intervention: Active tDCS and AE
Number of subjects: 148
Study 31672712 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS and AE
Number of subjects: 148
Study 31672712 — intervention group
Group type: EXPERIMENTAL
Intervention: Active tDCS and non-aerobic exercise (nAE)
Number of subjects: 148
Study 31672712 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS and nAE
Number of subjects: 148
Study 29718393 — intervention group
Group type: EXPERIMENTAL
Intervention: High HPV-18 antibodies (third quartile)
Number of subjects: 0
Study 29718393 — intervention group
Group type: EXPERIMENTAL
Intervention: High HPV-18 antibodies (fourth quartile)
Number of subjects: 0
Study 29718393 — intervention group
Group type: EXPERIMENTAL
Intervention: High HPV-16 antibodies
Number of subjects: 0
Study 26814256 — intervention group
Group type: EXPERIMENTAL
Intervention: DETERx IN
Number of subjects: 39
Study 26814256 — intervention group
Group type: EXPERIMENTAL
Intervention: DETERx PO
Number of subjects: 39
Study 26814256 — intervention group
Group type: COMPARATOR
Intervention: OXY‐IR IN
Number of subjects: 39
Study 24998104 — intervention group
Group type: EXPERIMENTAL
Intervention: Lignocaine with pethidine 30mg
Number of subjects: 45
Study 24998104 — intervention group
Group type: EXPERIMENTAL
Intervention: Lignocaine with ketoprofen 100mg
Number of subjects: 45
Study 24998104 — intervention group
Group type: COMPARATOR
Intervention: Lignocaine alone
Number of subjects: 45
Study 24998104 — intervention group
Group type: COMPARATOR
Intervention: Control (Lignocaine)
Number of subjects: 45
Study 24998104 — intervention group
Group type: EXPERIMENTAL
Intervention: Pethidine
Number of subjects: 45
Study 24998104 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketoprofen
Number of subjects: 45
Study 21244601 — intervention group
Group type: EXPERIMENTAL
Intervention: Concurrent subcutaneous interleukin‐2 (IL‐2), interferon‐α2b (IFN‐α) and granulocyte‐macrophage colony‐stimulating factor (GM‐CSF)
Number of subjects: 60
Study 21275334 — intervention group
Group type: EXPERIMENTAL
Intervention: Music therapy CD creation intervention
Number of subjects: 11
Study 21275334 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 11
Study 19026877 — intervention group
Group type: EXPERIMENTAL
Intervention: 6% sodium hypochlorite with EDTA
Number of subjects: 38
Study 19026877 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% chlorhexidine gluconate with EDTA
Number of subjects: 38
Study 19026877 — intervention group
Group type: EXPERIMENTAL
Intervention: Aquatine Endodontic Cleanser with EDTA
Number of subjects: 38
Study 19026877 — intervention group
Group type: EXPERIMENTAL
Intervention: Morinda citrifolia juice with EDTA
Number of subjects: 38
Study 19026877 — intervention group
Group type: EXPERIMENTAL
Intervention: 6% sodium hypochlorite with MTAD
Number of subjects: 38
Study 19026877 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% chlorhexidine gluconate with MTAD
Number of subjects: 38
Study 19026877 — intervention group
Group type: EXPERIMENTAL
Intervention: Aquatine Endodontic Cleanser with MTAD
Number of subjects: 38
Study 19026877 — intervention group
Group type: EXPERIMENTAL
Intervention: Morinda citrifolia juice with MTAD
Number of subjects: 38
Study 16192912 — intervention group
Group type: EXPERIMENTAL
Intervention: 2‐CdA + prednisone (P)
Number of subjects: 229
Study 16192912 — intervention group
Group type: COMPARATOR
Intervention: Chlorambucil (Chl) + prednisone (P)
Number of subjects: 229
Study 16192912 — intervention group
Group type: EXPERIMENTAL
Intervention: Chl + P followed by 2‐CdA + P
Number of subjects: 229
Study 16192912 — intervention group
Group type: EXPERIMENTAL
Intervention: 2‐CdA + P followed by Chl + P
Number of subjects: 229
Study 16192912 — intervention group
Group type: EXPERIMENTAL
Intervention: 2‐CdA + P
Number of subjects: 229
Study 16192912 — intervention group
Group type: COMPARATOR
Intervention: Chl + P
Number of subjects: 229
Study 12538369 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous vitamin E emulsion (all‐rac‐alpha‐tocopherol), 270 mg each, four doses between 16 h before and 48 h after surgery
Number of subjects: 40
Study 12538369 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 12538369 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous vitamin E emulsion (all‐rac‐alpha‐tocopherol)
Number of subjects: 40
Study 10802497 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypoallergenic amino acid‐based infant formula (AAF)
Number of subjects: 19
Study 10802497 — intervention group
Group type: COMPARATOR
Intervention: Previously best tolerated formula
Number of subjects: 19
Study 9074533 — intervention group
Group type: EXPERIMENTAL
Intervention: 201Tl for perfusion and 99mTc blood‐pool labeling
Number of subjects: 20
Study 8403515 — intervention group
Group type: EXPERIMENTAL
Intervention: rIL-2
Number of subjects: 52
Study 8403515 — intervention group
Group type: EXPERIMENTAL
Intervention: rIL-2 with IFN-alpha
Number of subjects: 52
Study 8403515 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 52
Study 8403515 — intervention group
Group type: EXPERIMENTAL
Intervention: rIL-2 or rIL-2 with IFN-alpha
Number of subjects: 52
Study 3811803 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupivacaine warmed to 37 degrees C (warm group)
Number of subjects: 40
Study 3811803 — intervention group
Group type: COMPARATOR
Intervention: Bupivacaine stored at 4 degrees C (cold group)
Number of subjects: 40
Study 31392990 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture plus standard care
Number of subjects: 124
Study 31392990 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 124
Study 29258076 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic indomethacin
Number of subjects: 0
Study 27039697 — intervention group
Group type: EXPERIMENTAL
Intervention: Long rest breaks
Number of subjects: 0
Study 27039697 — intervention group
Group type: COMPARATOR
Intervention: Short rest breaks
Number of subjects: 0
Study 24077370 — intervention group
Group type: EXPERIMENTAL
Intervention: Strength training sessions (twice per week) + in-water training
Number of subjects: 27
Study 24077370 — intervention group
Group type: COMPARATOR
Intervention: In-water training only
Number of subjects: 27
Study 22309790 — intervention group
Group type: EXPERIMENTAL
Intervention: Accelerated partial breast irradiation (APBI) via external beam with IMRT, 16 daily fractions of 270 cGy to a total dose of 4320 cGy.
Number of subjects: 310
Study 22309790 — intervention group
Group type: EXPERIMENTAL
Intervention: APBI treatment stratified by ASTRO risk groups.
Number of subjects: 310
Study 22309790 — intervention group
Group type: EXPERIMENTAL
Intervention: APBI treatment
Number of subjects: 310
Study 20808103 — intervention group
Group type: EXPERIMENTAL
Intervention: Citalopram
Number of subjects: 0
Study 20808103 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 17197818 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of amprenavir, lopinavir and ritonavir (400 mg/day)
Number of subjects: 0
Study 17197818 — intervention group
Group type: EXPERIMENTAL
Intervention: Optimized nucleoside reverse transcriptase inhibitors
Number of subjects: 0
Study 15738535 — intervention group
Group type: EXPERIMENTAL
Intervention: Trastuzumab plus chemotherapy (paclitaxel followed by fluorouracil, epirubicin, and cyclophosphamide)
Number of subjects: 42
Study 15738535 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy (paclitaxel followed by fluorouracil, epirubicin, and cyclophosphamide)
Number of subjects: 42
Study 15738535 — intervention group
Group type: EXPERIMENTAL
Intervention: Trastuzumab plus chemotherapy
Number of subjects: 42
Study 15738535 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy
Number of subjects: 42
Study 12002924 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam + Propofol
Number of subjects: 60
Study 12002924 — intervention group
Group type: COMPARATOR
Intervention: Placebo + Propofol
Number of subjects: 60
Study 12002924 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam + Propofol (with supplemental propofol)
Number of subjects: 60
Study 12002924 — intervention group
Group type: COMPARATOR
Intervention: Placebo + Propofol (with supplemental propofol)
Number of subjects: 60
Study 7956294 — intervention group
Group type: EXPERIMENTAL
Intervention: Humid‐Vent Filter
Number of subjects: 11
Study 7956294 — intervention group
Group type: EXPERIMENTAL
Intervention: Bennett Cascade 2 Humidifier
Number of subjects: 11
Study 7956294 — intervention group
Group type: COMPARATOR
Intervention: Pall Ultipor Filter
Number of subjects: 11
Study 2445214 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclosporine
Number of subjects: 224
Study 2445214 — intervention group
Group type: COMPARATOR
Intervention: Antilymphoblast azathioprine
Number of subjects: 224
Study 29569715 — intervention group
Group type: EXPERIMENTAL
Intervention: HPV self-collection brush (RIATOL qPCR HPV genotyping test)
Number of subjects: 35354
Study 29569715 — intervention group
Group type: EXPERIMENTAL
Intervention: Opt-in group (offered the opportunity to order an HPV self-sampling brush)
Number of subjects: 35354
Study 29569715 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard recall letter
Number of subjects: 35354
Study 29569715 — intervention group
Group type: COMPARATOR
Intervention: No intervention
Number of subjects: 35354
Study 29569715 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-sampling strategy
Number of subjects: 35354
Study 29569715 — intervention group
Group type: EXPERIMENTAL
Intervention: hrHPV positive testing
Number of subjects: 35354
Study 29569715 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-sampler DNA concentration
Number of subjects: 35354
Study 28259855 — intervention group
Group type: EXPERIMENTAL
Intervention: Restrictive fluid regimen (≤3.0 L in the first 24 hours)
Number of subjects: 3000
Study 28259855 — intervention group
Group type: COMPARATOR
Intervention: Liberal fluid regimen (≥5.4 L in the first 24 hours)
Number of subjects: 3000
Study 26147373 — intervention group
Group type: EXPERIMENTAL
Intervention: Newly designed thermal gown
Number of subjects: 100
Study 26147373 — intervention group
Group type: COMPARATOR
Intervention: Standard cotton cloth
Number of subjects: 100
Study 23186785 — intervention group
Group type: EXPERIMENTAL
Intervention: NF135.C10
Number of subjects: 5
Study 23186785 — intervention group
Group type: COMPARATOR
Intervention: NF54
Number of subjects: 5
Study 23186785 — intervention group
Group type: EXPERIMENTAL
Intervention: NF135.C10 and NF54
Number of subjects: 5
Study 21262888 — intervention group
Group type: EXPERIMENTAL
Intervention: Short sleep duration and irregular sleep schedules in obese children
Number of subjects: 308
Study 21262888 — intervention group
Group type: COMPARATOR
Intervention: Regular sleep patterns and longer sleep duration
Number of subjects: 308
Study 21262888 — intervention group
Group type: EXPERIMENTAL
Intervention: High variance in sleep duration
Number of subjects: 308
Study 21262888 — intervention group
Group type: COMPARATOR
Intervention: Average sleep duration of 8 hours per night
Number of subjects: 308
Study 19226541 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-steroidal anti-inflammatory drugs (NSAIDs) used for less than the study duration
Number of subjects: 0
Study 19226541 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-ASA NSAIDs used for less than the study duration
Number of subjects: 0
Study 19226541 — intervention group
Group type: EXPERIMENTAL
Intervention: Longer duration of NSAID use
Number of subjects: 0
Study 17044084 — intervention group
Group type: EXPERIMENTAL
Intervention: LD + ENT treatment
Number of subjects: 30
Study 15569202 — intervention group
Group type: EXPERIMENTAL
Intervention: Alternative therapy use
Number of subjects: 290
Study 15569202 — intervention group
Group type: COMPARATOR
Intervention: Radiotherapy treatment
Number of subjects: 290
Study 11022070 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 intra-articular injections of 40 mg triamcinolone acetonide
Number of subjects: 37
Study 11022070 — intervention group
Group type: COMPARATOR
Intervention: 1 mL physiological saline solution (placebo)
Number of subjects: 37
Study 11022070 — intervention group
Group type: EXPERIMENTAL
Intervention: Triamcinolone group
Number of subjects: 37
Study 11022070 — intervention group
Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 37
Study 11022070 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 37
Study 9288302 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional endoscopic sinus surgery (FES)
Number of subjects: 150
Study 9288302 — intervention group
Group type: COMPARATOR
Intervention: Caldwell‐Luc (C‐L) operations
Number of subjects: 150
Study 9288302 — intervention group
Group type: EXPERIMENTAL
Intervention: Both FES and C‐L operations
Number of subjects: 150
Study 8143886 — intervention group
Group type: EXPERIMENTAL
Intervention: zolpidem, 10 mg for 2 weeks (nights 8-21)
Number of subjects: 21
Study 8143886 — intervention group
Group type: COMPARATOR
Intervention: placebo (nights 8-21)
Number of subjects: 21
Study 8143886 — intervention group
Group type: COMPARATOR
Intervention: placebo (nights 22-28)
Number of subjects: 21
Study 3539672 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous subcutaneous insulin infusion (CSII)
Number of subjects: 45
Study 3539672 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple insulin injections (MI)
Number of subjects: 45
Study 3539672 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 45
Study 29909698 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 readings (awaken)
Number of subjects: 4277